Monday, October 26, 2026 · Daily editionET --:--:--

Not recruiting yet

Pelvic-Restricted vs. Pelvic-Free Robot-Assisted Gait Training in Stroke Patients

NCT07365384 · Meltem Gunes Akinci · Updated 26 Jan 2026

What is being tested
RoboGait® Pelvic-Free Mode; RoboGait® Pelvic-Restricted Mode; Conventional Rehabilitation
For
Stroke; Hemiplegia; Gait Disorder, Sensorimotor; Balance Impairment; Fear of Falling
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 75 years. About 36 people. The full rules are on the registry page.
Where
Not stated
When
Starts or started 15 Jan 2026, ends April 2026. Registered 26 Jan 2026.
Results
None posted yet.

In the researchers' words

This randomized controlled clinical trial aims to compare the effects of pelvic-free versus pelvic-restricted robot-assisted gait training (RAGT) on gait pattern, balance, and fear of falling in stroke patients. Stroke survivors often experience gait impairments, reduced balance, and fear of falling, which limit independence and quality of life. Conventional physiotherapy requires high intensity and repetition but is restricted by therapist capacity. Robotic gait systems provide intensive, repetitive, and safe training; however, most limit pelvic motion, potentially disrupting natural gait patterns and balance strategies. A total of 36 participants with chronic stroke (≥6 months post-stroke, age ≥18 years, hemiplegic gait disorder, Functional Ambulation Category ≥2) will be randomized into two groups: (1) pelvic-free RAGT plus conventional rehabilitation, or (2) pelvic-restricted RAGT plus conventional rehabilitation. Interventions will consist of 8 RAGT sessions (twice weekly) and 20 conventional rehabilitation sessions (five times weekly) over 4 weeks. Primary outcomes include gait analysis parameters (gait speed, step length, cadence, temporal symmetry index) and clinical measures such as the Berg Balance Scale, Functional Ambulation Category, Motricity Index (lower limb), and Falls Efficacy Scale-International. Assessments will be performed at baseline and after 4 weeks…
ClinicalTrials.gov, NCT07365384